This article is educational and does not replace medical advice. Prescription medication requires review by a licensed clinician and, when appropriate, a valid prescription. Compounded medications are not FDA-approved, and the FDA does not verify their safety, effectiveness or quality before marketing. Treatment eligibility is an individual clinical decision.
This page is maintained. Prices are re-read at source and dated; evidence is checked against the published trial. Newest across the site: news · research · corrections.
Peptide provider directory
Evaluating peptide telehealth providers requires the same rigor as GLP-1 programs, plus honest regulatory disclosure. This directory explains what to look for; we list providers only after verification.
Quick answer
We hold peptide providers to a strict standard: licensed clinician oversight, licensed pharmacy dispensing, honest regulatory status, and no research-chemical sales. Provider listings are added only after verification.
Where should you read next?
Verify a peptide provider
The checklist
Peptide safety
Sourcing and injectable risks
Peptide legality
What 'research use only' means
Research vs prescription
The safety gap
Sources
- U.S. Food and Drug Administration — approval and compounding status.
- Primary clinical literature cited on child pages.
- Our methodology and source standards.
How the dates on this page work. Manufacturer self-pay prices — NovoCare and LillyDirect — were re-read on the manufacturers’ own published price guides on 4 August 2026. Figures captured from third-party provider websites carry the date we read that provider’s page, which may be earlier; where it is, the row says so. We do not restamp a figure we have not re-read.